Effect of budesonide aqueous nasal spray on hypothalamic-pituitary-adrenal axis function in children with allergic

Kenneth T Kim1, Nathan Rabinovitch, Thomas Uryniak

  • 1Allergy, Asthma & Respiratory Care Medical Center, Long Beach, California 90806, USA. drkkim@wcctrials.com

Insights

Budesonide aqueous nasal spray is safe for young children with allergic rhinitis. This study found no significant impact on hypothalamic-pituitary-adrenal (HPA) axis function in children aged 2-5 years.

Area of Science:

  • Pediatric Allergy and Immunology
  • Endocrinology
  • Pharmacology

Background:

  • Intranasal corticosteroids are standard for adult allergic rhinitis.
  • Pediatric systemic corticosteroid exposure raises safety concerns.
  • Evaluating HPA axis function is crucial for pediatric corticosteroid safety.

Purpose of the Study:

  • To assess the impact of budesonide aqueous nasal spray on HPA axis function in young children with allergic rhinitis.
  • To determine safety and tolerability of budesonide in pediatric patients.
  • To evaluate effects at the recommended once-daily dose.

Main Methods:

  • A 6-week, multicenter, double-blind, placebo-controlled study.
  • 78 children aged 2-5 years with allergic rhinitis participated.
  • HPA axis function assessed via plasma cortisol levels post-cosyntropin stimulation.

Main Results:

  • No significant differences in plasma cortisol levels between budesonide and placebo groups.
  • HPA axis function remained unaffected in the budesonide treatment group.
  • Safety and tolerability profiles were comparable to placebo.

Conclusions:

  • Budesonide aqueous nasal spray is safe and well-tolerated in children aged 2-5 years.
  • No measurable suppressive effects on HPA axis function were observed.
  • Supports the use of budesonide for pediatric allergic rhinitis.
Abstract

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Hypothalamic-Pituitary Axis01:37

Hypothalamic-Pituitary Axis

The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...